Explore more publications!

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on April 13, 2026

Birdeye Expands into Singapore, Bringing the #1 Marketing Platform to Southeast Asia
Amway Reports Sustained Growth in 2025 in the ESAN Region: A 3.5% Increase in Sales, Reaching $439 Million
4Life Clinical Study

4Life Clinical Study

Crystal Facilities Management Expands Pest Control Services Across Saudi Arabia
Krown Technologies Achieves ISO/IEC 27001:2022 Certification for Information Security Management
Philippines IT-BPM Leaders Rethink Growth Beyond Headcount
Applications Open for DNDA26 Awards: Celebrating Humanity-Centered Design for Societal Impact and Global Well-Being
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support
Ballad Health’s program for assisting uninsured patients earns national award for its community-based approach to serving rural Appalachia
AIM ImmunoTech Provides Routine Update on Annual Filings
South Korea Bioactive Sphingolipid Market Outlook: Ceramide-Led Growth Accelerates as Doosan Corporation
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions